Oxamniquine

CHEMBL847 Phase 4 Zugelassen Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

279.3 g/mol

LogP

2.2

Phase

4

An anthelmintic drug used to treat schistosomiasis caused by Schistosoma mansoni, particularly in Africa and South America. It works by causing spastic paralysis in the worm, leading to its dislodgment from blood vessels and destruction by the host immune system.

Molekularmasse

279,3300 g/mol

LogP

2,20

TPSA

90,10 Å²

Lipinski-Regel der Fünf

Bestanden

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D-Struktur

SVG PNG

Cite this structure

Embed this structure

SMILES

CC(C)NCC1CCc2cc(CO)c([N+](=O)[O-])cc2N1

InChI

InChI=1S/C14H21N3O3/c1-9(2)15-7-12-4-3-10-5-11(8-18)14(17(19)20)6-13(10)16-12/h5-6,9,12,15-16,18H,3-4,7-8H2,1-2H3

Molecular Formula

C14H21N3O3

HBD / HBA

3 / 5

Rotierbare Bindungen

4

Schwere Atome

20

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

An anthelmintic drug used to treat schistosomiasis caused by Schistosoma mansoni, particularly in Africa and South America. It works by causing spastic paralysis in the worm, leading to its dislodgment from blood vessels and destruction by the host immune system.

Yes, Oxamniquine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL847. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 4612. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Suchen Sie patientenfreundliche Informationen?

Oxamniquine auf PillFYI

Struktur

Schnelldaten

Formel: C14H21N3O3

Externe Links

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.